The time of day of immunotherapy infusions does appear to affect patient outcomes. But convincing the wider oncology ...
Pancreatic cancer is one of the deadliest types of cancer, with fewer than 13% of people diagnosed with it surviving for more ...
An applicant returned a scaled-down concept plan to the zoning board, to develop medical office buildings in Holmdel near the ...
A new study from Memorial Sloan Kettering Cancer Center shows good results for patients with pancreatic cancer. They used a ...
Discover the 7 major risk factors for liver cancer, from viral hepatitis to genetics. Learn how lifestyle changes and early ...
A new type of mRNA vaccine, added to standard cancer treatment, could help some patients with pancreatic cancer live longer.
Immune cells might be reprogrammed to use the body’s fructose — a naturally occurring sugar — as an energy source that supercharges them to fight cancer, researchers at Memorial Sloan Kettering Cancer ...
For women with breast cancer, breast-conserving therapy (BCT) is associated with improved sexual well-being, compared to ...
The first patient with myelodysplastic syndrome has received iadademstat plus azacitidine in a phase 1 trial at the Medical ...
Learn about the new AI collaboration between Memorial Sloan Kettering Cancer Center and Amazon Web Services, and its potential to transform cancer care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results